TELA Bio(TELA) - 2024 Q2 - Quarterly Results

Exhibit 99.1 TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance MALVERN, PA, August 12, 2024 -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today reported financial results for the second quarter ended June 30, 2024. Recent Highlights · Reported revenue of $16.1 million in the second quarter, representing growth of 11% over the prior year period of 2023; · Ap ...